These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 21757830)

  • 1. Excess copper chelating therapy for Wilson disease induces anemia and liver dysfunction.
    Harada M; Miyagawa K; Honma Y; Hiura M; Shibata M; Matsuhashi T; Abe S; Harada R; Tabaru A
    Intern Med; 2011; 50(14):1461-4. PubMed ID: 21757830
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and safety of oral chelators in treatment of patients with Wilson disease.
    Weiss KH; Thurik F; Gotthardt DN; Schäfer M; Teufel U; Wiegand F; Merle U; Ferenci-Foerster D; Maieron A; Stauber R; Zoller H; Schmidt HH; Reuner U; Hefter H; Trocello JM; Houwen RH; Ferenci P; Stremmel W;
    Clin Gastroenterol Hepatol; 2013 Aug; 11(8):1028-35.e1-2. PubMed ID: 23542331
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ultrastructural identification of iron and copper accumulation in the liver of a male patient with Wilson disease.
    Shiono Y; Hayashi H; Wakusawa S; Yano M
    Med Electron Microsc; 2001 Mar; 34(1):54-60. PubMed ID: 11479773
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Diagnosis and treatment of Wilson disease in Japan].
    Shimizu N
    Rinsho Shinkeigaku; 2019 Sep; 59(9):565-569. PubMed ID: 31474637
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Importance of a Liver Biopsy in the Management of Wilson Disease.
    Oe S; Honma Y; Yabuki K; Morino K; Kumamoto K; Hayashi T; Kusanaga M; Ogino N; Minami S; Shibata M; Abe S; Harada M
    Intern Med; 2020 Jan; 59(1):77-81. PubMed ID: 31511488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myelopathy secondary to copper deficiency as a complication of treatment of Wilson's disease.
    Lozano Herrero J; Muñoz Bertrán E; Ortega González I; Gómez Espín R; López Espín MI
    Gastroenterol Hepatol; 2012 Dec; 35(10):704-7. PubMed ID: 22609346
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of Wilson disease with ammonium tetrathiomolybdate: IV. Comparison of tetrathiomolybdate and trientine in a double-blind study of treatment of the neurologic presentation of Wilson disease.
    Brewer GJ; Askari F; Lorincz MT; Carlson M; Schilsky M; Kluin KJ; Hedera P; Moretti P; Fink JK; Tankanow R; Dick RB; Sitterly J
    Arch Neurol; 2006 Apr; 63(4):521-7. PubMed ID: 16606763
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acquired sideroblastic anaemia induced by a copper-chelating agent.
    Perry AR; Pagliuca A; Fitzsimons EJ; Mufti GJ; Williams R
    Int J Hematol; 1996 Jul; 64(1):69-72. PubMed ID: 8757970
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Wilson's disease treatment by triethylene tetramine dihydrochloride (trientine, 2HCl): long-term observations.
    Morita J; Yoshino M; Watari H; Yoshida I; Motohiro T; Yamashita F; Okano Y; Hashimoto T
    Dev Pharmacol Ther; 1992; 19(1):6-9. PubMed ID: 1307347
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trientine induced colitis during therapy for Wilson disease: a case report and review of the literature.
    Boga S; Jain D; Schilsky ML
    BMC Pharmacol Toxicol; 2015 Nov; 16():30. PubMed ID: 26589720
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Switching Pharmacological Treatment in Wilson Disease: Case Report and Recommendations.
    Leung M; Wu Lanzafame J; Medici V
    J Investig Med High Impact Case Rep; 2020; 8():2324709619896876. PubMed ID: 31920114
    [No Abstract]   [Full Text] [Related]  

  • 12. Prospective pilot study of a single daily dosage of trientine for the treatment of Wilson disease.
    Ala A; Aliu E; Schilsky ML
    Dig Dis Sci; 2015 May; 60(5):1433-9. PubMed ID: 25605552
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trientine-induced neurological deterioration in a patient with Wilson's disease.
    Kim B; Chung SJ; Shin HW
    J Clin Neurosci; 2013 Apr; 20(4):606-8. PubMed ID: 23274038
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Wilson Disease: Diagnosis, Treatment, and Follow-up.
    Schilsky ML
    Clin Liver Dis; 2017 Nov; 21(4):755-767. PubMed ID: 28987261
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Therapy of Wilson disease].
    Smolarek C; Stremmel W
    Z Gastroenterol; 1999 Apr; 37(4):293-300. PubMed ID: 10378366
    [TBL] [Abstract][Full Text] [Related]  

  • 16. WTX101 - an investigational drug for the treatment of Wilson disease.
    Weiss KH; Członkowska A; Hedera P; Ferenci P
    Expert Opin Investig Drugs; 2018 Jun; 27(6):561-567. PubMed ID: 29806946
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Wilson's disease in paediatric age: diagnosis and treatment. Recent advances].
    Palumbo E
    Recenti Prog Med; 2008 Nov; 99(11):561-4. PubMed ID: 19209540
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Wilson's disease.
    Walshe JM
    Lancet; 2007 Mar; 369(9565):902. PubMed ID: 17368141
    [No Abstract]   [Full Text] [Related]  

  • 19. [The onset of psychiatric disorders and Wilson's disease].
    Benhamla T; Tirouche YD; Abaoub-Germain A; Theodore F
    Encephale; 2007 Dec; 33(6):924-32. PubMed ID: 18789784
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Wilson disease: an update].
    Seo JK
    Korean J Hepatol; 2006 Sep; 12(3):333-63. PubMed ID: 16998287
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.